1Williamsson C, Wennerblom J, Tingstedt B, et al. A wait-and- see strategy with subsequent self-expanding metal stent on de- mand is superior to prophylactic bypass surgery for unresectable periampullary cancer [J]. HPB, 2016, 18 (1): 107-112.
2Grimm I S, Baron T H. Biliary Stents for Palliation of Ob- structive Jaundice: Choosing the Superior Endoscopic Manage- ment Strategy [J]. Gastroenterology, 2015, 149 (1): 20-22.
3Garcea G, Ong S L, Dennison A R, et al. Palliation of malig- nant obstructive jaundice [J]. Dig Dis Sci, 2009, 54 (6):1184-1198.
4Shepherd H A, Royle G, Ross A P, et al. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial [J]. Br J Surg, 1988, 75 (12): 1166-1168.
5Andersen J R, Sorensen S M, Kruse A, et al. Randomised trial of endoscopic endoprosthesis versus operative bypass in malig- nant obstructive jaundice [J]. Gut, 1989, 30 (8) : 1132-1135.
6Bornman P C, Harries-Jones E P, Tobias R, et al. Prospective controlled trial of transhepatic biliary endoprosthesis versus by- pass surgery for incurable carcinoma of head of pancreas [J]. Lancet, 1986, 1 (8472): 69-71.
7Smith A C, Dowsett J F, Russell R C, et al. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bileduct obstruction [ J ]. Lancet, 1994, 344 ( 8938 ) : 1655-1660.
8Watanapa P, Williamson R C. Surgical palliation for pancreatic cancer: developments during the past two decades [J]. Br J Surg, 1992, 79 (1): 8-20.
9Van Den Bosch R P, Van Eijck C H, Mulder P G, et al. Serum CA19-9 determination in the management of pancreatic cancer [J]. Hepatogastroenterology, 1996, 43 (9): 710-713.
10Schwarz A, Beger H G. Biliary and gastric bypass or stenting in nonresectable periampullary cancer: analysis on the basis of controlled trials [J]. Int J Pancreatol, 2000, 27 (1): 51-58.
